期刊文献+

通脉化浊汤对冠心病大鼠血脂的影响 被引量:6

Tongmaihuazhuo Decoction on Blood Lipid in Rats with Coronary Atherosclerotic Heart Disease
下载PDF
导出
摘要 [目的]观察通脉化浊汤对冠心病大鼠血脂的影响,为临床应用提供实验依据。[方法]按体重将大鼠随机分为正常组、模型组、通脉化浊汤高、中、低剂量组、血脂康组共6组,除正常组外,其余5组以维生素D_370 万IU/kg3天内灌胃,饲以高脂饲料,并于给药前一天腹腔注射垂体后叶素30U/kg,描记Ⅱ导心电图,建立冠心病血脂异常模型大鼠,检测TC、TG、HDL、LDL水平。[结果]与模型组相比,通脉化浊汤高、中、低剂量组均可明显降低TC、LDL水平,并提高HDL水平;与血脂康组比较,通脉化浊汤高、中、低剂量组与其无显著差异。[结论]通脉化浊汤可降低冠心病大鼠的血脂,验证和探讨了中医药在冠心病治疗中的作用,为指导临床治疗提供了客观的参考指标。 [ Objective ] To observe the effect of Tongmaihuazhuo decoction on blood lipid in rats with coro- nary atherosclerotic heart disease (CHD) and provide experimental basis for clinical applications. [ Methods ] Rats were divided into six groups:normal group, model group, Tongmaihuazhuo decoction high, middle and low dosage group and Xuezhikang group according to the weight, except for normal group, the other five groups were lavaged into stomach with vitamin D3 70 10000IU/kg in three days, raise high lipid feed, intraperitoneal injec- tion pituitrin 30U/kg before administration day, record lI ECG, establish dyslipidemia in rats models with CHD, test the level of TC, TG, HDL and LDL. r Results ] As compared with model group, the level of TC and LDL was obviously reduced, and the level of HDL was increased in Tongmaihuazhuo decoction high, middle and low dosage groups; As compared with Xuezhikang group, there wasn't prominent differences among Tong- maihuazhuo decoction high, middle and low dosage groups. [ Conclusion ] Tongmaihuazhuo decoction can reduce blood lipid in rats with CHD,that validate and discuss the effect of traditional chinese medicine treatment,to guide the clinical treatment provide an objective reference indicator.
机构地区 辽宁中医药大学
出处 《实用中医内科杂志》 2010年第3期23-25,共3页 Journal of Practical Traditional Chinese Internal Medicine
关键词 血脂 冠心病 大鼠 通脉化浊汤 lipid coronary heart disease rats Tongrnaihuazhuo decoction
  • 相关文献

参考文献7

二级参考文献22

  • 1赵水平.高密度脂蛋白的研究现状[J].中国动脉硬化杂志,2005,13(6):673-675. 被引量:22
  • 2吴淑梅 梅美珍 等.实验性动脉粥样硬化病理模型的复制.动脉粥样硬化实验技术[M].中国病理生理学会动脉粥样硬化专业委员会,1989.1-10. 被引量:1
  • 3[1]Karlsson H,Leanderson P,Tagesson C,et al.Lipoproteomics Ⅱ:Mapping of proteins in high-density lipoprotein using twodimensional gel electrophoresis and mass spectrometry.Proteomics,2005,.5:1431-2445,2004,110:3355-2359. 被引量:1
  • 4[5]Durrington PN,Mackness B,Mackncss MI.Paraoxonase and atherosclerosis.Arterioscler Thromb Vasc Biol,2001,21:473-480. 被引量:1
  • 5[6]Girona J,LaVille AE,Hereas M.Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages.Free Radic Biol Med,1997,23:658-667. 被引量:1
  • 6[8]Parhami F,Basseri B,Hwang J,et al.High 2 density lipoproteinre gulatescalcifi cationofvascularcells.Circ Res,2002,91:570-576. 被引量:1
  • 7吴淑梅,动脉粥样硬化实验技术,1989年,1页 被引量:1
  • 8Lin Lee Y C,Biochemistry,1981年,20卷,6474页 被引量:1
  • 9Endo A.The discovery and development of HMG-CoA reductase inhibitors[J].Lipid Res,2003,33(4):1569-1582. 被引量:1
  • 10Artaud-Wild SM,Connor SL,Sexton G.Differences in coronary mortality can be explained differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland[J].Circulation,1993,99(5):2771-2779. 被引量:1

共引文献253

同被引文献48

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部